Nawal Ouzren

Nawal has 20 years of expertise across a wide range of business roles, including clinical development, operational and strategic management roles within the pharmaceutical industry. Nawal currently serves as CEO at Sensorion, a Euronext listed biopharmaceutical company headquartered in France.

A chemical engineer by training, Nawal started her career at GE in operations management, manufacturing and quality and then held executive roles at Baxter International, Baxalta and Shire before joining Sensorion in 2017.

Nawal offers first-hand experience in biologics and novel gene therapies and is a current serving non-executive director of Arena Pharmaceuticals, the US headquartered biopharmaceutical company.